子宫内膜增生症的诊治进展

Research progress of endometrial hyperplasia

子宫内膜增生症(EH)随人口老龄化及人民群众健康保障需求的日益增长需要更规范化的诊治。EH是子宫内膜癌前病变,EH组织病理学检查结果为不规则增生的腺体数量增多伴或不伴细胞异型性。2015年美国妇产科医师学会(ACOG)联合美国妇科肿瘤学会(SGO)和2016年英国皇家妇产科学会(RCOG)相继发表子宫内膜增生症管理指南,提出各种原因引起的雌、孕激素失衡,子宫内膜过度的雌激素暴露可能导致EH发生,治疗以使用孕激素和子宫切除术为主。笔者拟对近年EH的病理学分类、诊断和治疗等的进展进行综述。

With the aging of the population and people′s health needs, standardized diagnosis and treatment of endometrial hyperplasia （EH） are becoming more and more important. EH is a precancerous lesion of endometrial hyperplasia, endometrial hyperplasia and endometrial hyperplasia of the number of irregular hyperplasia of the gland with or without cell. According to the cellular atypia nothing more than hyperplasia, atypical hyperplasia; in 2016 2015, the United States and Britain have issued guidelines for the management of endometrial hyperplasia, the various causes of excessive imbalance of estrogen and progesterone in endometrial estrogen exposure is a risk factor for the occurrence, treatment with progesterone and uterine resection. In this paper, the pathological classification, diagnosis and treatment of endometrial hyperplasia were reviewed.